Aurinia Pharmaceuticals, Inc. (AUPH)
15.89
-0.36
(-2.22%)
USD |
NASDAQ |
Dec 29, 16:00
16.00
+0.11
(+0.69%)
Pre-Market: 08:23
Aurinia Pharmaceuticals EPS Diluted (Quarterly): 0.232 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.1378 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
| ProMIS Neurosciences, Inc. | -5.928 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 31.55M |
| Revenue (Quarterly) | 73.47M |
| Total Expenses (Quarterly) | 41.92M |
| Enterprise Value | 1.821B |
| Gross Profit Margin (Quarterly) | 88.87% |
| Profit Margin (Quarterly) | 42.95% |
| Earnings Yield | 3.53% |
| Operating Earnings Yield | 4.33% |
| Normalized Earnings Yield | 4.040 |